Description
Sildigra XL Plus
Sildigra XL Plus is identified by the supplied product name as a sildenafil-containing medicine. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction. The brand name itself is not verified here as an official regulated product, so the overview below is based on the verified active ingredient, sildenafil.
Active Ingredient and Medicine Class
Active ingredient: sildenafil.
Medicine class: PDE5 inhibitor, a vasodilating medicine that acts on the nitric oxide–cGMP pathway.
Established Medical Uses
Sildenafil is established for the treatment of erectile dysfunction in adult men. Regulatory labeling for sildenafil products describes this as the main approved use. Some sildenafil products are also approved for other conditions, but those uses are product-specific and are not assumed for this listing.
How It Works
During sexual stimulation, nitric oxide increases cyclic guanosine monophosphate (cGMP) in penile tissue, which relaxes smooth muscle and helps increase blood flow. Sildenafil inhibits PDE5, the enzyme that breaks down cGMP, thereby enhancing and prolonging this natural erectile response. It does not cause an erection without sexual stimulation.
Important Safety Information
Sildenafil must not be used with organic nitrates or other nitric oxide donors, because the combination can cause a dangerous fall in blood pressure. It must also not be used with riociguat, a guanylate cyclase stimulator. Caution is needed in people with cardiovascular disease, low blood pressure, left ventricular outflow obstruction, or autonomic dysfunction. Sildenafil can also interact with alpha-blockers, some antihypertensives, and strong CYP3A4 inhibitors such as ritonavir, ketoconazole, itraconazole, and erythromycin, which can increase sildenafil exposure or blood-pressure effects.
Possible Side Effects
Common adverse effects include headache, flushing, dyspepsia, nasal congestion, abnormal vision, back pain, myalgia, nausea, dizziness, and rash. Important serious reactions can include prolonged erection (priapism), sudden hearing changes, and clinically significant hypotension, especially with interacting medicines. Hypersensitivity reactions have also been reported.
Scientific Evidence
Peer-reviewed reviews and meta-analyses show that sildenafil improves erectile function and the likelihood of successful intercourse compared with placebo in men with erectile dysfunction. Published evidence also supports a generally predictable safety profile, with adverse effects mainly related to its vasodilatory action and occasional visual symptoms at higher exposure.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration — VIAGRA (sildenafil citrate) tablets, prescribing information
- DailyMed — VIAGRA- sildenafil citrate tablet, film coated
- Fink HA et al. — “Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.” BMJ (2002). PubMed
